Get Sample Pages - Australia Lab Automation Market Size, Trends & Forecast 2026-2032

Australia Lab Automation Market Research Report: Trends, Forecast & Opportunities (2026-2032)

By Product Type (Equipment / Devices, Software, Services), By End User (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Institute......s), By Application (Clinical Diagnostics, Drug Discovery & Development, Research Applications) Read more

Healthcare
Mar 2026
Pages 175
Report Format: PDF, Excel, PPT

Australia Lab Automation Market Report Key Takeaways:

The Australia Lab Automation Market size was valued at around USD 114 million in 2025 and is projected grow from USD 121 million in 2026 to USD 175 million by 2032, exhibiting a CAGR of 6.34% during the forecast period.
By Product Type, the Equipment / Devices segment represented a significant share of about 55% in the Australia Lab Automation Market in 2026.
By End User, the Pharmaceutical & Biotechnology Companies seized a significant share of about 42% in the Australia Lab Automation Market in 2026.
Leading companies are Thermo Fisher Scientific, Siemens Healthineers, F. Hoffmann-La Roche Ltd, Danaher Corporation, Agilent Technologies, Tecan Group Ltd., Hamilton Company, Revvity, Inc., Abbott Laboratories, Becton, Dickinson and Company (BD), and Others.

Market Insights & Analysis: Australia Lab Automation Market (2026-32):

The Australia Lab Automation Market size was valued at around USD 114 million in 2025 and is projected grow from USD 121 million in 2026 to USD 175 million by 2032, exhibiting a CAGR of 6.34% during the forecast period, i.e., 2026-32.

Australia’s laboratory automation market has demonstrated steady historical expansion, supported by rising diagnostic demand and sustained healthcare investment. According to the Australian Institute of Health and Welfare, total health expenditure exceeded USD 178 billion in 2023–24, reflecting strong infrastructure funding. High volumes of pathology and diagnostic testing have encouraged laboratories to adopt automation technologies to improve throughput and accuracy. Over time, centralized laboratory networks and technology upgrades have strengthened automation penetration across clinical and research settings.

Current market conditions are driven by strong institutional demand, particularly from hospitals and diagnostic laboratories. Major providers such as Sonic Healthcare and Healius Limited continue expanding high-throughput laboratory infrastructure to manage increasing sample volumes. The Australian Bureau of Statistics reports that healthcare and social assistance account for over 15% of national employment, indicating sustained sector expansion . This institutional dominance reinforces demand for automation to ensure efficiency, scalability, and rapid turnaround times.

Regulatory and policy frameworks have played a critical role in supporting market growth through digital transformation initiatives. The Australian Digital Health Agency is advancing national programs focused on electronic health records and data interoperability, enabling integration with automated laboratory systems. In addition, government funding through Medicare continues to allocate billions of dollars annually toward pathology services, reinforcing testing demand. These policy measures support the adoption of automation technologies by improving data management, compliance, and operational efficiency in laboratories.

Looking ahead, the market outlook remains positive, supported by demographic shifts and ongoing technological innovation. According to the Australian Bureau of Statistics, the population aged 65 and above is projected to exceed 20% in the coming decades, increasing diagnostic demand . Companies such as Thermo Fisher Scientific are investing in AI-enabled automation and advanced workflows to enhance productivity. Combined with continued digital health initiatives and infrastructure investments, these factors are expected to sustain long-term growth in laboratory automation adoption.

Australia Lab Automation Market Recent Developments:

2025 : Roche Diagnostics reported increased adoption of automation in clinical laboratories, emphasizing pre-analytical and workflow automation to improve efficiency and reduce manual errors across global and Australia-linked lab networks.

Australia Lab Automation Market Scope:

Category	Segments
By Product Type	(Equipment / Devices, Software, Services),
By End User	(Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes),
By Application	(Clinical Diagnostics, Drug Discovery & Development, Research Applications)

Australia Lab Automation Market Driver:

Rising Diagnostic Testing Demand

Rising diagnostic testing demand has emerged as the most influential structural driver of Australia’s laboratory automation market, driven by the increasing burden of chronic diseases. According to the Australian Institute of Health and Welfare, around 6 in 10 Australians live with at least one long-term health condition, while chronic diseases account for nearly two-thirds of the total disease burden. Conditions such as cardiovascular disease, diabetes, and cancer require continuous monitoring and frequent testing. This sustained clinical demand directly increases laboratory workloads, necessitating scalable and automated diagnostic solutions.

The measurable impact of this driver is evident in the growing volume and frequency of diagnostic testing across institutional end users. Data from the Australian Bureau of Statistics indicates that cardiovascular disease alone affects approximately 1.3 million Australians, while diabetes contributes to over 21,000 deaths annually, reinforcing the need for ongoing diagnostic evaluation. Hospitals and diagnostic laboratories are experiencing higher sample volumes due to repeated testing requirements for chronic disease management. This sustained increase in testing frequency has intensified the need for automation to maintain efficiency, accuracy, and turnaround times.

Government funding has further strengthened this structural demand by expanding access to diagnostic services. The Australian government committed approximately USD 5.4 billion in 2025 to strengthen Medicare, increasing accessibility to primary care and pathology testing. This policy-driven expansion is directly contributing to higher testing volumes and sustained laboratory utilization. Combined with digital health initiatives led by the Australian Digital Health Agency, these factors establish a clear cause-and-effect relationship, where increased healthcare access drives diagnostic demand and accelerates laboratory automation adoption.

Market Segmentation
Introduction
1. Product Definition
2. Research Process
3. Assumptions
Executive Summary
Australia Lab Automation Market Policies, Regulations, and Product Standards
Australia Lab Automation Market Trends & Developments
Australia Lab Automation Market Dynamics
1. Growth Factors
2. Challenges
Australia Lab Automation Market Hotspot & Opportunities
Australia Lab Automation Market Outlook, 2022-2032F
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Outlook
  1. By Product Type- Market Size & Forecast 2022-2032, USD Million
    1. Equipment / Devices
      1. Automated Liquid Handling Systems
      2. Robotic Systems & Workstations
      3. Sample Storage & Retrieval Systems
      4. Microplate Readers / Analytical Instruments
      5. Sample Preparation Systems
    2. Software
    3. Services
  2. By End User- Market Size & Forecast 2022-2032, USD Million
    1. Hospitals & Diagnostic Laboratories
    2. Pharmaceutical & Biotechnology Companies
    3. Academic & Research Institutes
  3. By Application- Market Size & Forecast 2022-2032, USD Million
    1. Clinical Diagnostics
    2. Drug Discovery & Development
    3. Research Applications
  4. By Company
    1. Competition Characteristics
    2. Market Share & Analysis
Australia Lab Automation Equipment / Devices Market Outlook, 2022-2032
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Outlook
  1. By End User- Market Size & Forecast 2022-2032, USD Million
  2. By Application- Market Size & Forecast 2022-2032, USD Million
Australia Lab Automation Software Market Outlook, 2022-2032
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Outlook
  1. By End User- Market Size & Forecast 2022-2032, USD Million
  2. By Application- Market Size & Forecast 2022-2032, USD Million
Australia Lab Automation Services Market Outlook, 2022-2032
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Outlook
  1. By End User- Market Size & Forecast 2022-2032, USD Million
  2. By Application- Market Size & Forecast 2022-2032, USD Million
Australia Lab Automation Market Key Strategic Imperatives for Success & Growth
Competitive Outlook
1. Company Profiles
  1. Thermo Fisher Scientific
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  2. Siemens Healthineers
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  3. F. Hoffmann-La Roche Ltd
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  4. Danaher Corporation
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  5. Agilent Technologies
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  6. Tecan Group Ltd.
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  7. Hamilton Company
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  8. Revvity, Inc.
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  9. Abbott Laboratories
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  10. Becton, Dickinson and Company (BD)
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO GET THE FREE SAMPLE PAGES

Name *

Email ID *

Country *